16 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
15633995	66	Control of hepatitis C: a medicinal chemistry perspective.	University of Wollongong
15801859	40	Anchor-GRIND: filling the gap between standard 3D QSAR and the GRid-INdependent descriptors.	Imim/Universitat Pompeu Fabra
15080998	21	Capped dipeptide phenethylamide inhibitors of the HCV NS3 protease.	Irbm, Mrl Rome
14741292	18	Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 2: tertiary amides.	Shire Biochem
14741291	19	Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 1: Sulfonamides.	Shire Biochem
12951122	20	Further SAR studies on novel small molecule inhibitors of the hepatitis C (HCV) NS5B polymerase.	Shire Biochem
12643923	22	Glycine alpha-ketoamides as HCV NS3 protease inhibitors.	Pharmaceutical Research Institute
11844706	30	Evolution, synthesis and SAR of tripeptide alpha-ketoacid inhibitors of the hepatitis C virus NS3/NS4A serine protease.	Irbm, Mrl Rome
24022489	18	Structural basis of mycobacterial inhibition by cyclomarin A	Novartis Institute For Tropical Diseases
23955344	9	Pre-existent asymmetry in the human cyclooxygenase-2 sequence homodimer.	University of Michigan Medical School
11861807	8	A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid.	Istituto Di Chimica Biomolecolare
17973363	13	Discovery of a tetrazole-based growth hormone secretagogue: 4-(hydroxybutyl)carbamic acid 2-{5-[1-(2-amino-2-methylpropionylamino)-2- benzyloxyethyl]tetrazol-1-yl}ethyl ester (BMS-317180).	Bristol-Myers Squibb Pharmaceutical Research Institute
14561086	14	Thermal denaturation: a method to rank slow binding, high-affinity P38alpha MAP kinase inhibitors.	Boehringer Ingelheim Pharmaceuticals